Alpha Cognition Announces Pricing of Public Offerings
Alpha Cognition, a biopharmaceutical company focused on neurodegenerative disorders, announced the pricing of its upsized public offering of 8,695,653 common shares at $5.75 per share. The Company also granted underwriters a 30-day option to purchase up to 1,184,592 additional shares. The offering is expected to close on November 13, 2024, pending customary conditions.
Alpha Cognition Announces Pricing of Public Offerings